Tag: Thyroid-associated ophthalmopathy

Progress in pathogenesis and treatment of the elevated intraocular pressure resulted from thyroid associated ophthalmopathy

Authors: Guo Zhenfeng,  Zhao Liang,  Sun Fengyuan DOI: 10.3760/cma.j.cn115989-20191022-00459 Published 2021-07-10 Cite asChin J Exp Ophthalmol, 2021, 39(7): 661-664. Abstract                              [View PDF] [Read Full Text] In adult orbital diseases, thyroid associated ophthalmopathy (TAO) is of very high incidence rate, and it can seriously affect patients’ […]

The importance of basic research and drug development for thyroid-associated ophthalmopathy

Author: Fan Xianqun DOI: 10.3760/cma.j.cn115989-20200812-00582 Published 2020-11-10 Cite as Chin J Exp Ophthalmol, 2020,38(11): 905-909. Abstract                               [View PDF] [Read Full Text] Thyroid-associated ophthalmopathy (TAO) is an organ specific autoimmune disease with complex pathogenesis.In recent years, great progress has been made in the pathogenesis of TAO […]

Distribution of monocyte subtypes in peripheral blood of patients with thyroid-associated ophthalmopathy

Authors: Xu Jianan,  Ye Huijing,  Chen Rongxin,  Chen Guo,  Chen Jingqiao,  Yang Huasheng DOI: 10.3760/cma.j.cn115989-20200712-00489 Published 2020-11-10 Cite as Chin J Exp Ophthalmol, 2020,38(11): 944-950. Abstract                              [View PDF] [Read Full Text] Objective To explore the distribution of different subsets of monocyte in peripheral blood of […]

The tear biomarkers in thyroid associated ophthalmopathy and its clinical significance

Authors: Lu Yi,  Zhou Huifang DOI: 10.3760/cma.j.cn115989-20201023-00710 Published 2020-11-10 Cite as Chin J Exp Ophthalmol, 2020,38(11): 993-996. Abstract                               [View PDF] [Read Full Text] Thyroid associated ophthalmopathy(TAO) is the most common orbital disease in the clinic.The ocular surface damage in TAO can be commonly seen and […]

Evaluation of thyroid-associated ophthalmopathy activity by using magnetic resonance fat quantification technology

Authors: Liu Gang,  Zhu Rongrong,  Sheng Xunlun,  Jiao Huajie,  Ha Ruoshui DOI: 10.3760/cma.j.issn.2095-0160.2019.12.008 Published 2019-12-10 Cite as Chin J Exp Ophthalmol, 2019,37(12): 976-981. Abstract                               [View PDF] [Read Full Text] Objective To explore the value of magnetic resonance fat quantification technology (MR mDixon-quant) in evaluating thyroid-associated ophthalmopathy […]

A study on the establishment of co-culture system of peripheral blood mononuclear cells with orbital fibroblasts and the secretion of IL-6 and IL-17A induced by phytagglutinin in thyroid associated ophthalmopathy

Authors: Pan Yuan,  Xu Xueliang,  Tan Jia,  Xu Bei,  Zhang Lingli DOI: 10.3760/cma.j.issn.2095-0160.2016.08.005 Published 2016-08-10 Cite as Chin J Exp Ophthalmol, 2016,34(8): 692-698. Abstract                              [Download PDF] [Read Full Text] Background The pathogenic mechanism of thyroid associated ophthalmopathy (TAO) is still unclear, which is considered to be […]

Current research of hyaluronic acid and thyroid-associated ophthalmopathy

Authors:Chen Xiaoling,  He Weimin DOI: 10.3760/cma.j.issn.2095-0160.2016.11.018 Published 2016-11-10 Cite as Chin J Exp Ophthalmol, 2016,34(11): 1047-1050. Abstract                               [Download PDF] [Read Full Text] Thyroid-associated ophthalmopathy (TAO) is a common orbital disease in the adults, and glycosaminoglycan deposits in the periorbital connective tissue is one of important pathological features.Hyaluronic acid is […]

Association of thyroid dysfunction with ocular surface damage in thyroid dysfunction patients without thyroid ophthalmopathy

Authors: Zhang Hongjuan,  Zhang Zuncheng,  Mao Chunjie DOI: 10.3760/cma.j.issn.2095-0160.2017.01.012 Published 2017-01-10 Cite as Chin J Exp Ophthalmol, 2017,35(1): 58-63. Abstract                              [Download PDF] [Read Full Text] Background It is determined that the patients with thyroid-associated ophthalmopathy (TAO) often occur dry-eye related symptoms due to increasing tear evaporation caused by […]

Diagnosis and treatment of upper eyelid retraction in thyroid-associated ophthalmopathy

Authors: Mou Pei,  Wei Ruili DOI: 10.3760/cma.j.issn.2095-0160.2017.03.022 Published 2017-03-10 Cite as Chin J Exp Ophthalmol, 2017,35(3): 286-288. Abstract                            [Download PDF] [Read Full Text] Thyroid associated ophthalmopathy (TAO) is often shown as upper eyelid retraction, conjunctival hyperemia and edema, proptosis, diplopia, strabismus and decreased visual acuity.It is difficult to […]

Promoting effects of insulin-like growth factor-1 on proliferation of orbital fibroblasts derived from thyroid associated ophthalmopathy

Authors: Dai Jialing,  He Weimin,  Luo Mengqi DOI: 10.3760/cma.j.issn.2095-0160.2017.09.008 Published 2017-09-10 Cite as Chin J Exp Ophthalmol, 2017,35(9): 805-810. Abstract                              [Download PDF] [Read Full Text] Background Thyroid associated ophthalmopathy (TAO) is an autoimmune disease.Current research on the pathogenesis focuses on common autoantigen.Insulin-like growth factor-1 receptor (IGF-1R) is necessary […]